In addition, deleterious mutations in multiple direct or downstream immune effectors, notably CLEC7A[11], STAT3[12], and CARD9[13], have been found in human cohorts with high prevalence of chronic mucocutaneous candidiasis (CMC) and have been recapitulated and studied in mice. Here, CARD9 is linked to chronic mucocutaneous candidiasis.